Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;42(5):551-566.
doi: 10.1002/humu.24186. Epub 2021 Mar 1.

A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons

Affiliations

A global analysis of the reconstitution of PTEN function by translational readthrough of PTEN pathogenic premature termination codons

Sandra Luna et al. Hum Mutat. 2021 May.

Abstract

The PTEN tumor suppressor gene is mutated with high incidence in tumors and in the germline of patients with cancer predisposition or with macrocephaly associated with autism. PTEN nonsense mutations generating premature termination codons (PTC) and producing nonfunctional truncated PTEN proteins are frequent in association with human disease. However, there are no studies addressing the restoration of full-length PTEN proteins from the PTC-mutated PTEN gene by translational readthrough. Here, we have performed a global translational and functional readthrough analysis of the complete collection of PTEN PTC somatic or hereditary mutations found in tumors or in the germline of patients (disease-associated PTEN PTCome), and we set standards for the analysis of the potential of readthrough functional reconstitution in disease-relevant genes. Our analysis indicates that prevalent pathogenic PTEN PTC mutations are susceptible to PTEN functional restoration in response to readthrough-inducing compounds. Comprehensive readthrough analyses of disease-associated PTComes will be valuable tools for the implementation of readthrough-based precision interventions in specific groups of patients.

Keywords: nonsense mutation; premature termination codon; translational readthrough; tumor suppressor.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Alimonti, A., Carracedo, A., Clohessy, J. G., Trotman, L. C., Nardella, C., Egia, A., Salmena, L., Sampieri, K., Haveman, W. J., Brogi, E., Richardson, A. L., Zhang, J., & Pandolfi, P. P. (2010). Subtle variations in Pten dose determine cancer susceptibility. Nature Genetics, 42(5), 454-458. https://doi.org/10.1038/ng.556
    1. Alvarez-Garcia, V., Tawil, Y., Wise, H. M., & Leslie, N. R. (2019). Mechanisms of PTEN loss in cancer: It's all about diversity. Seminars in Cancer Biology, 59, 66-79. https://doi.org/10.1016/j.semcancer.2019.02.001
    1. Andrés-Pons, A., Rodríguez-Escudero, I., Gil, A., Blanco, A., Vega, A., Molina, M., Pulido, R., & Cid, V. J. (2007). In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN. Cancer Research, 67(20), 9731-9739. https://doi.org/10.1158/0008-5472.CAN-07-1278
    1. Asiful Islam, M., Alam, F., Kamal, M. A., Gan, S. H., Wong, K. K., & Sasongko, T. H. (2017). Therapeutic suppression of nonsense mutation: An emerging target in multiple diseases and thrombotic disorders. Current Pharmaceutical Design, 23(11), 1598-1609. https://doi.org/10.2174/1381612823666161122142950
    1. Atkinson, J., & Martin, R. (1994). Mutations to nonsense codons in human genetic disease: Implications for gene therapy by nonsense suppressor tRNAs. Nucleic Acids Research, 22(8), 1327-1334. https://doi.org/10.1093/nar/22.8.1327

Publication types

LinkOut - more resources